FDA.reportPublic FDA data

Xeljanz 10 MG Oral Tablet

RxCUI
2048568
RxNorm name
Xeljanz 10 MG Oral Tablet
Display name
Xeljanz 10 MG Oral Tablet
Full name
Xeljanz 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cf74ba2f-afc5-4baa-8594-979c889a5831Xeljanz 10 MG Oral Tablet [PSN] · tofacitinib 10 MG Oral Tablet [Xeljanz] [SBD] · Xeljanz 10 MG (as tofacitinib citrate 16 MG) Oral Tablet [SY] · Xeljanz 10 MG Oral Tablet [SY]453These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ ® (tofacitinib) tablets, for oral use XELJANZ ® (tofacitinib) oral solution XELJANZ ® XR (tofacitinib) extended-release tablets, for oral use Initial U.S. Approval: 201220260312
68e3d6b2-7838-4d2d-a417-09d919b43e13Xeljanz 10 MG Oral Tablet [PSN] · tofacitinib 10 MG Oral Tablet [Xeljanz] [SBD] · Xeljanz 10 MG (as tofacitinib citrate 16 MG) Oral Tablet [SY] · Xeljanz 10 MG Oral Tablet [SY]417These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ ® (tofacitinib) tablets, for oral use XELJANZ ® (tofacitinib) oral solution XELJANZ ® XR (tofacitinib) extended-release tablets, for oral use Initial U.S. Approval: 201220260327